Latest Cross Company (ATX) Headlines Tim Hortons Inc.

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Cross [A.T.] Company (ATX) Headlines

Tim Hortons Inc. announces 2013 fourth quarter results:
CNW Group - Thu Feb 20, 6:30AM CST
Same-store sales growth finished ahead of full year Quarterly dividend increased 23.1% to $0.32 per common share; New share repurchase program of up to $440 million announced

Troponin I (CAS 77108-40-8) - Global Market Research Report
M2 - Tue Feb 04, 8:53AM CST
Research and Markets (http://www.researchandmarkets.com/research/blk5tf/troponin_i_cas) has announced the addition of the "Troponin I (CAS 77108-40-8) Market Research Report 2013" report to their offering. Troponin I (CAS 77108-40-8) Market Research Report 2013 presents comprehensive data on troponin I markets globally and regionally (Europe, Asia, North America etc.) The Troponin I (CAS 77108-40-8) Market Research Report 2013 includes troponin I description, covers its application areas and related patterns. It overviews troponin I market, names troponin I producers and indicates its suppliers. Besides, the Troponin I (CAS 77108-40-8) Market Research Report 2013 provides troponin I prices in regional markets. In addition to the above the Troponin I (CAS 77108-40-8) Market Research Report 2013 determines troponin I consumers in the market. We can analyze the following elements for each chemical product in any country or region: - Capacities and production - Consumption volume and structure - Market price trends - Exports and imports - Existing technologies - Feedstock market condition - Market news digest - Market forecast The Troponin I (CAS 77108-40-8) Market Research Report 2013 can feature: - Market condition and estimations, market forecast - Chemical product ranges, trademarks, analogous products, application areas - Regional and global producers, consumers and traders (including contact details) Key Topics Covered: 1. TROPONIN I: GENERAL INFORMATION 1.1. Properties 1.2. Composition, information on ingredients 1.3. Hazards identification 1.4. Handling and storage 1.5. Toxicological & ecological information 1.6. Transport information 2. TROPONIN I END-USE SECTOR 2.1. Application areas 2.2. Patents 3. TROPONIN I MARKET WORLDWIDE. MANUFACTURERS AND SUPPLIERS OF TROPONIN I (INCLUDING CONTACT DETAILS). 3.1. Manufacturers of troponin i 3.2. Suppliers of troponin i 4. CURRENT TROPONIN I MARKET PRICES 4.1. Europe 4.2. Asia 4.3. North America 5. TROPONIN I CONSUMERS For more information visit http://www.researchandmarkets.com/research/bl...onin_i_cas

Downgrade Alert for AT Cross (ATX)
Comtex SmarTrend(R) - Tue Jan 07, 7:14AM CST
AT Cross (NASDAQ:ATX) was downgraded from Buy to Neutral at DA Davidson today. The stock closed yesterday at $21.63 on volume of 113,000 shares, above average daily volume of 43,000. A. T. Cross Company manufactures and sells writing instruments. The Company's products consist of ball point and fountain pens, Selectip rolling ball pens, mechanical pencils, desk sets, ball-point refills, and pen-based computing products. The Company also designs and distributes timepieces, business accessories, and Costa Del Mar sunglasses.

Costa Inc. Announces the Meeting Date for the Special Meeting of the Shareholders and the Expiration of the Hart-Scott-Rodino Waiting Period in Connection With Merger
GlobeNewswire - Mon Dec 30, 7:45AM CST
Costa Inc. (Nasdaq:ATX) announced today that its shareholders will vote on its previously-announced merger agreement with a subsidiary of Essilor International SA at a special meeting scheduled for January 30, 2014. Details concerning the merger agreement and related merger as well as the special meeting are set forth in the definitive proxy statement mailed to the Costa Inc. shareholders in connection with the meeting.

Costa Inc. Announces Record Date for Special Meeting in Connection With Merger
GlobeNewswire - Fri Dec 13, 7:45AM CST
Costa Inc. (Nasdaq:ATX) today announced that it has established the close of business on December 17, 2013 as the record date for its special meeting of shareholders to consider and vote on, among other things, the merger of GWH Acquisition Sub Inc. ("Merger Sub"), an indirect wholly-owned subsidiary of Essilor International SA ("Essilor"), with and into Costa Inc., and the other transactions contemplated by the previously announced merger agreement, dated as of November 7, 2013, among Costa Inc., Essilor and Merger Sub.

COSTA INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
PR Newswire - Wed Nov 20, 1:25PM CST
Rigrodsky & Long, P.A.:

SHAREHOLDER ALERT: Acquisition of Costa, Inc. (ATX) by Essilor International May Be Detrimental to the Interests of Costa, Inc. Shareholders
PR Newswire - Wed Nov 20, 1:23PM CST
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Costa Inc. ("Costa" or the "Company") (NasdaqGM: ATX) for potential breaches of fiduciary duties in connection with their conduct related to the sale of the Company to Essilor International in a cash deal valued at approximately $270 million. Under the terms of the proposed transaction, Costa stockholders will receive $21.50 for each share of Costa common stock they own.

Retail Industry Stock Outlook - Nov 2013 - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Tue Nov 19, 9:18AM CST
Retail Industry Stock Outlook - Nov 2013 - Industry Outlook

Retail Industry Stock Outlook - Nov 2013 - Zacks Analyst Interviews
Zacks Equity Research - Zacks Investment Research - Tue Nov 19, 9:18AM CST
Retail Industry Stock Outlook - Nov 2013 - Zacks Analyst Interviews

SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Costa, Inc.
Business Wire - Thu Nov 14, 8:15PM CST
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Costa, Inc. ("Costa" or the "Company") (Nasdaq: ATX) relating to the proposed acquisition of the Company by Essilor International ("Essilor").

INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Costa Inc. (ATX) Board of Directors For Possible Breaches of Fiduciary Duty in Connection With the Proposed Sale of the Company to Essilor International
Business Wire - Thu Nov 14, 4:27PM CST
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Costa Inc. ("Costa" or the "Company") (NasdaqGM:ATX) for potential breaches of fiduciary duties in connection with their conduct related to the sale of the Company to Essilor International in a cash deal valued at approximately $270 million. Under the terms of the proposed transaction, Costa stockholders will receive $21.50 for each share of Costa common stock they own.

Law Offices of Todd M. Garber Announces Investigation of Costa Inc.
Business Wire - Tue Nov 12, 7:00PM CST
The Law Offices of Todd M. Garber announces that it is investigating potential claims against the Board of Directors of Costa Inc. ("Costa" or the "Company") (NASDAQ:ATX) related to the proposed acquisition of the Company by Essilor International. The transaction is valued at approximately $270 million, or $21.50 per share.

Ryan & Maniskas, LLP Announces Investigation of Costa Inc.
PR Newswire - Tue Nov 12, 10:06AM CST
Ryan & Maniskas, LLP is investigating potential claims against the board of directors of Costa Inc. ("Costa" or the "Company") (NASDAQ: ATX) concerning possible breaches of fiduciary duty and other violations of law related to the Company's efforts to sell the Company to Essilor International in a cash deal valued at approximately $270 million.

Costa Inc. Board of Directors Under Investigation by Glancy Binkow & Goldberg LLP
Business Wire - Mon Nov 11, 7:00PM CST
Glancy Binkow & Goldberg LLP is investigating potential claims against the Board of Directors of Costa Inc. ("Costa" or the "Company") (NASDAQ:ATX) related to the proposed acquisition of the Company by Essilor International. The transaction is valued at approximately $270 million, or $21.50 per share.

Law Firm Brower Piven Announces Investigation of Costa Inc. Proposed Buyout
Business Wire - Mon Nov 11, 3:25PM CST
The securities litigation firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty to current shareholders of Costa Inc. ("Costa" or the "Company") (NasdaqGM: ATX) and other violations of state law by the board of directors of Costa relating to the proposed buyout of the Company by Essilor International S.A. The firm's investigation seeks to determine, among other things, whether the board of directors of Costa breached their fiduciary duties by failing to maximize shareholder value.

Costa Inc. and Essilor International Merger May Not Be in Shareholders' Best Interests
PR Newswire - Mon Nov 11, 1:25PM CST
Shareholder rights attorneys at Robbins Arroyo LLP are investigating the proposed acquisition of Costa Inc. (NASDAQ: ATX) by Essilor International (EPA: EI). Costa and Essilor announced the signing of a definitive merger agreement pursuant to which Essilor will acquire Costa. Under the terms of the agreement, holders of Costa will receive $21.50 in cash for each share owned.

Attention ATX Shareholders: The Proposed Buyout of Costa Inc by Essilor International is Under Investigation By The Young Law Firm
Business Wire - Mon Nov 11, 11:10AM CST
The Young Law Firm, a national shareholder litigation firm, is investigating potential claims concerning the proposed acquisition of Costa Inc ("Costa" or the "Company") (Nasdaq: ATX) by Essilor International. The investigation concerns whether the proposed buyout price represents fair value for the sale of the Company and whether the interests of the Company's public shareholders have been adequately protected. Pursuant to the terms of the proposed transaction, shareholders of Costa will receive $21.50 per share. The transaction is valued at approximately $270 million.

LEVI & KORSINSKY, LLP Notifies Investors of COSTA, INC. of Claims of Breaches of Fiduciary Duty by Board of the Company in Connection with Sale of the Company to Essilor International
Business Wire - Mon Nov 11, 11:10AM CST
Levi & Korsinsky notifies investors of Costa, Inc. ("Costa" or the "Company") (Nasdaq: ATX) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Essilor International ("Essilor").

COSTA INC. SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Costa Inc. (ATX) Over the Proposed Sale of the Company to Essilor International
Business Wire - Mon Nov 11, 10:19AM CST
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Costa Inc. ("Costa" or the "Company") (NasdaqGM: ATX) for potential breaches of fiduciary duties in connection with their conduct related to the sale of the Company to Essilor International in a cash deal valued at approximately $270 million. Under the terms of the proposed transaction, Costa stockholders will receive $21.50 for each share of Costa common stock they own.

Costa Inc. (ATX) Stock Research Links

ATX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action: Key Details for Investors

Updated Category News Views 158

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 153

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 119

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 183

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 244

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 203

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 211

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 138

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 365

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 139

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading

Top 5 Most Recently Viewed Articles

BlueLinx Expands Its Reach with New Portland Distribution Hub

Updated Category News Views 147

BlueLinx Unveils New Distribution Center in Portland BlueLinx Holdings Inc. (NYSE: BXC) has officially opened a greenfield distribution center in Portland, enhancing its operational footprint in the Pacific Northwest. This facility is a significant addition to the company’s distribution capabilities, as it strategically positions BlueLinx to serve the growing demands of...

Continue Reading
IBA Partners with China Gold to Advance X-ray Technological Growth

Updated Category News Views 255

Strategic Partnership for Industry Advancement In a significant move for the irradiation processing industry, IBA (Ion Beam Applications S.A., EURONEXT) has joined forces with China Gold Irradiation (CGI), the premier irradiation service provider in China. This collaboration is set to elevate the standards of irradiation services by incorporating advanced X-ray...

Continue Reading
Amerant Bank and Partners Generate Support for Local Charity

Updated Category News Views 189

Generous Collaboration: Amerant Bank's Community Impact In a heartwarming display of community spirit, Amerant Bank has partnered with Sedano’s Supermarkets and Fresco y Más to make a significant difference in the lives of underserved children and families. The culmination of their efforts was marked by a grand check presentation to Centro Mater, a renowned...

Continue Reading
Mediar Therapeutics Advances Phase 2 Trial for Rare Lung Disease

Updated Category News Views 123

Mediar Therapeutics Initiates Phase 2 WISPer Trial Mediar Therapeutics, Inc., a pioneering clinical-stage biotechnology company, has reached a major milestone by dosing the first patient in its Phase 2 WISPer clinical trial. This trial focuses on evaluating MTX-463, a first-in-class therapy designed to combat idiopathic pulmonary fibrosis (IPF). The primary goal of this...

Continue Reading
Chime Biologics and Waterstone Unite for ADC Innovation

Updated Category News Views 242

Chime Biologics and Waterstone Forge a New Path in ADC Development Chime Biologics and Waterstone Pharmaceuticals have officially announced a strategic partnership designed to enhance the capabilities and efficiencies within the Antibody-Drug Conjugate (ADC) industry. By combining their expertise, both companies aim to provide integrated services that boost the...

Continue Reading